1-3 of 3
Roger Williams
Close
Sort by
Journal Articles

Induction of Immune Responses and Improved Survival after Infusions of T Cells Armed with Anti-CD3 X Anti-Her2/ Neu Bispecific Antibody in Stage IV Breast Cancer Patients (Phase I).

Lawrence G. Lum, MD, DSC, Ritesh Rathore, MD, Don Dizon, MD, Ding Wang, MD, Zaid Al-Kadhimi, MD, Immunotherapy Team Roger Williams Hospital, Joseph P. Uberti, MD, PhD, Voravit Ratanatharathorn, MD
Journal: Blood
Blood (2007) 110 (11): 2747.
https://doi.org/10.1182/blood.V110.11.2747.2747
Published: 2007
Journal Articles

Enhanced Anti-Breast Cancer Cytotoxicity after Autologous Peripheral Blood Stem Cell Transplant (PBSCT) by Boosting with Multiple Infusions of Activated T Cells (ATC) Armed with Anti-CD3 x Anti-Her2 Bispecific Antibody (Her2Bi) Prior to PBSCT.

Lawrence G. Lum, MD, DSc, Zaid Al-Kadhimi, MD, Cassara Skuba, BA, Roger Williams Hospital BMT/Immunotherapy Team, Voravit Ratanatharathorn, MD, Joseph P. Uberti, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2748.
https://doi.org/10.1182/blood.V110.11.2748.2748
Published: 2007
Journal Articles

Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy

Paul Harmatz, Ellen Butensky, Keith Quirolo, Roger Williams, Linda Ferrell, Thomas Moyer, Daniel Golden, Lynne Neumayr, Elliott Vichinsky
Journal: Blood
Blood (2000) 96 (1): 76–79.
https://doi.org/10.1182/blood.V96.1.76
Published: 2000